Category Archives: Nano Medicine

A new research document with the title GlobalHealthcare Nanotechnology (Nanomedicine) Market Report covering detailed analysis, Competitive landscape, forecast, and strategies has been added to the Insight Partners. The study covers geographic analysis that includes regions like North America, Europe and Asia-Pacific, South America, Middle East, and Africa. The report will help users gain market insights, future trends, and growth prospects for forecast to 2027.

Nanotechnology is among the most developing technologies in the present scenario. Nanotechnology is a term used when technical improvements occur at 0.1 to 100 nm scale. Nanomedicine is a field of nanotechnology that includes medicine development at the molecular level for prevention, diagnosis, treatment of diseases, and even redevelopment of tissues and organs. Hence, it aids in preserving and advances human health. Nanomedicine provides a remarkable solution for numerous life-threatening conditions such as Parkinson, Alzheimers, cancer, diabetes, blood-related diseases, lungs, orthopedic problems, neurological, and cardiovascular system.

Download Sample PDF Brochure of this research study at https://www.theinsightpartners.com/sample/TIPRE00007260/

Top Leading Companies

1. Sanofi2. Abbott3. Pfizer, Inc.4. CombiMatrix Corporation5. GE Healthcare6. Celgene Corporation7. Johnson & Johnson Services, Inc.8. Luminex Corporation9. Merck & Company, Inc.10. Nanosphere, Inc.

Our expert team is consistently working on updated data and information on the key players related business processes that value the market. For future strategies and predictions, we provide a special section regarding the COVID-19 situation.

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Healthcare Nanotechnology (Nanomedicine) market which would mention How the Covid-19 is Affecting the Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions, and Proposal for Disposable Incontinence Products (DIPs) Players to fight Covid-19 Impact.

The researchers have analyzed the competitive advantages of those involved in the industries. While historical years were taken as 2020 2027, the base year for the study was 2020. Similarly, the report has given its projection for the year 2020 apart from the outlook for years 2020 2027.

The objective of the researchers is to find out the sales, value, and status of the Healthcare Nanotechnology (Nanomedicine) industry at the international levels. While the status covers the years of 2020 2027, the forecast is for the period 2020 2027 that will enable market players to not only plan but also execute strategies based on the market needs.

The study wanted to focus on key manufacturers, competitive landscape, and SWOT analysis for the Healthcare Nanotechnology (Nanomedicine) market. Apart from looking into the geographical regions, the report concentrated on key trends and segments that are either driving or preventing the growth of the industry. Researchers have also focused on individual growth trends besides their contribution to the overall market.

An outline of the regional analysis:

Healthcare Nanotechnology (Nanomedicine) Market recent innovations and major events.

Additional highlights of the Healthcare Nanotechnology (Nanomedicine) market report:

Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 10+ companies.

Order a copy of this research study at https://www.theinsightpartners.com/buy/TIPRE00007260/

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

Call: +1-646-491-9876

Email:sales@theinsightpartners.com

See the rest here:
New Technology Developments in Healthcare Nanotechnology (Nanomedicine) Market to Grow during Forecast year 2020-2027 - re:Jerusalem

Beathan Report published a new report, titled, Nanomedicine Market. The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porters Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage.

The report offers key drivers that propel the growth in the global Nanomedicine market. These insights help market players in devising strategies to gain market presence. The research also outlined restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining potential in untapped regions.

Request Sample Report @ https://beathanreports.com/request-for-sample-report/9254

The research offers a detailed segmentation of the global Nanomedicine market. Key segments analyzed in the research include type, drive system, application and geography. Extensive analysis of sales, revenue, growth rate, and market share of each type, drive system, application, and geography for the historic period and the forecast period is offered with the help of tables.

The market is analyzed based on regions and competitive landscape in each region is mentioned. Regions discussed in the study include North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). These insights help to devise strategies and create new opportunities to achieve exceptional results.

Key market players

Major competitors identified in this market include Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck, Pfizer, Nanosphere, Epeius Biotechnologies, Cytimmune Sciences, Nanospectra Biosciences, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Request Discount About This Report @ https://beathanreports.com/discount-request-on-report/9254

Key Benefits:

The market player positioning segment provides an understanding of the current position of the market players active in the Nanomedicine industry.

Based on the Type:

Quantum dots

Nanoparticles

Nanoshells

Nanotubes

Nanodevices

Based on the Application:

oncology

Infectious diseases

Cardiology

Orthopedics

Others

Request For Customization About This Report @ https://beathanreports.com/request-for-customization/9254

Key offerings of the report:

Contact Us

Beathan Report,

4004 W Lake Sammamish,

Pkway B9 Redmond,

WA 98052 United States.

Tel: +44 115 888 3028

Web: http://www.beathanreports.com

About Us

At Beathan Report, we understand that the research we provide is only as good as the outcome it inspires. These reports are generated by well-renowned publishers on the basis of the data acquired from an extensive research and credible business statistics. Thats why we are proud to provide the widest range of research products, multilingual 24/7 customer support and dedicated custom research services to deliver the insights you need to achieve your goals. Take a look at few of our aspects that makes Beathan Report an asset to your business.

Follow this link:
Market Forecast Report on Nanomedicine Market 2020-2025 - The Think Curiouser

IndustryGrowthInsights, one of the worlds leading market research firms has rolled out a new report on Healthcare Nanotechnology market. The report is integrated with crucial insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Global Healthcare Nanotechnology Market to figure out and study market needs, market size, and competition. The report provides information about the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats faced by key players.

The report also includes the impact of the ongoing global crisis i.e. COVID-19 on the Healthcare Nanotechnology market and what the future holds for it. The pandemic of Coronavirus (COVID-19) has landed a major blow to every aspect of life globally. This has lead to various changes in market conditions. The swiftly transforming market scenario and initial and future assessment of the impact are covered in the report.

Request a sample Report of Healthcare Nanotechnology Market: https://industrygrowthinsights.com/request-sample/?reportId=168254

The report is fabricated by tracking the market performance since 2015 and is one of the most detailed reports. It also covers data varying according to region and country. The insights in the report are easy to understand and include pictorial representations. These insights are also applicable in real-time scenarios. Components such as market drivers, restraints, challenges, and opportunities for Healthcare Nanotechnology are explained in detail. Since the research team is tracking the data for the market from 2015, therefore any additional data requirement can be easily fulfilled.

The scope of the report has a wide spectrum extending from market scenarios to comparative pricing between major players, cost, and profit of the specified market regions. The numerical data is supported by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, and PESTLE analysis. The statistics are depicted in a graphical format for a clear picture of facts and figures.

The generated report is strongly based on primary research, interviews with top executives, news sources, and information insiders. Secondary research techniques are utilized for better understanding and clarity for data analysis.

The Healthcare Nanotechnology Market is divided into the following segments to have a better understanding:

By Application:

AnticancerCNS ProductAnti-infectiveOthers

By Type:

NanomedicineNano Medical DevicesNano DiagnosisOthersHealthcare Nanotechnolog

By Geographical Regions:

Ask for Discount on Healthcare Nanotechnology Market Report at: https://industrygrowthinsights.com/ask-for-discount/?reportId=168254

The Healthcare Nanotechnology Market industry Analysis and Forecast 20192026 help clients with customized and syndicated reports holding key importance for professionals requiring data and market analytics. The report also calls for market-driven results providing feasibility studies for client requirements. IGI promises qualified and verifiable aspects of market data operating in the real-time scenario. The analytical studies are carried out ensuring client requirements with a thorough understanding of market capacities in the real-time scenario.

Some of the prominent companies that are covered in this report:

Key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. Following is the list of key players:

AmgenTeva PharmaceuticalsAbbottUCBRocheCelgeneSanofiMerck & CoBiogenStrykerGilead SciencesPfizer3M CompanyJohnson & JohnsonSmith & NephewLeadiant BiosciencesKyowa Hakko KirinTakedaIpsenEndo InternationalHealthcare Nanotechnolog

*Note: Additional companies can be included on request

Reasons you should buy this report:

IndustryGrowthInsights provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Customized Report and Inquiry for the Healthcare Nanotechnology Market Report: https://industrygrowthinsights.com/enquiry-before-buying/?reportId=168254

About Us:

Our reports are more than just research reports to us. They are tools that enable us to maintain long-term relationships with our clients whom we honor and cherish. Our clients business growth is integral for not only them but also us. This is what differentiates us from other market research companies.

At IGI, we provide our expertise and guideline for success. Our team of efficient and experienced researchers and consultants provide progressive market intelligence reports that are accurate, authentic, and in-depth. This empowers the clients to make well-informed decisions.

Moreover, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries including chemicals and materials, energy, automobile, healthcare, consumer goods, and technology. Our deep understanding of many business environments across industries such as those mentioned above allows us to deliver tailor-made reports.

Contact Us:

Name: Alex MathewsPhone No.: +1 909 545 6473Email: [emailprotected] Website: https://industrygrowthinsights.com Address: 500 East E Street, Ontario, CA 91764, United States.

Read more:
Healthcare Nanotechnology Market Size 2020-2026 Review, Key Findings, Growth Strategy, Developing Technologies, Trends And Global Forecast By Regions...

KANAZAWA, Japan, Nov. 5, 2020 /PRNewswire/ --Researchers at Kanazawa University report, in Science how concentration gradients of particular molecules ('synthetic morphogens') can be produced in biological systems. Such gradients can be exploited for programming pattern formation, offering the promise of controlled tissue engineering.

Multicellular organisms can grow and develop thanks to so-called morphogens: molecules that provide positional information. They are produced in a source, from which they diffuse and build up a concentration gradient in their environment. Nearby cells can 'read' this gradient, therefore 'know' where they are in the organism and 'act' accordingly. Now, Satoshi Toda from Kanazawa University and colleagues report the successful engineering of a synthetic morphogen system that can be programmed.This achievement not only helps to understand how exactly morphogens encode positional information, but is also promising in the context of engineered tissue formation.

Toda who is a PI at the NanoLSI WPI at Kanazawa University, has in a few years become an expert on programming cell patterning and tissue self-assembly, and his team tackled the question of what a minimal synthetic morphogen signaling system looks like, with the synthetic system operating 'orthogonally' to biological (endogenous) morphogens, meaning that the endogenous and the synthetic system don't interfere.

The researchers adapted an existing synthetic receptor system called synNotch so that it worked for soluble green fluorescent proteins (GFPs) as the morphogen molecules.(The original synNotch system requires morphogen molecules to be connected to a cell membrane, i.e. be non-soluble.) They did so by designing so-called anchor cells that can capture a GFP molecule in solution. An anchor cell carrying a trapped GFP molecule is then detected by a receiver cell (through chemical docking).Toda and colleagues demonstrated that this approach worked in vitro: a concentration gradient of GFP morphogen and activated cells formed within about 24 hours.

The scientists then investigated how the shape of the morphogen gradient can be regulated. They found that for different anchor protein densities, different gradient shapes were obtained. In addition, the spatial distribution of the gradient could be influenced through the use of inhibitors (molecules blocking the anchorreceiver mechanism).Toda and colleagues concluded that synthetic morphogen gradients can be tuned so that shapes similar to those occurring in vivo are obtained.

Finally, the research team around Toda showed that it is possible to alter the 'interpretation' of the gradient. They designed different kinds of feedback circuits, for example one in which GFP detection leads to more GFP production, or one in which GFP detection leads to GFP inhibitor production.Via such circuit engineering combined with the morphogen and inhibitor sources, the scientists were able to produce binary and ternary domain structures.

The results of Toda and colleagues have promising application potential. Citing the researchers: "These synthetic morphogen platforms can program positional information without cross-talk to endogenous signaling pathways.Thus, it may be possible to deploy them in vivo as inert tools to probe or redirect [tissue] development."

Related figure

https://nanolsi.kanazawa-u.ac.jp/wp-content/uploads/2020/11/8ba2015f5ccca51facee7e5f23441248.jpg

Caption:Arbitrary proteins such as GFP can turn into a synthetic morphogen that forms a gradient pattern of gene expression.

Related website

Research Highlights NanoLSI Kanazawa University

https://nanolsi.kanazawa-u.ac.jp/en/achievements/achievements-13345/

Background

Morphogens

Morphogens are molecules that are essential for the biological process of pattern formation. They are produced in a source, after which they diffuse through surrounding tissue in an embryo, setting up concentration gradients in the process. These gradients then drive the biochemical reactions that ultimately lead to the formation of all the various tissues and organs in an organism. Kanazawa University's Satoshi Toda, a pioneer of programming multicellular self-organizing structures, and colleagues have now shown that it is possible to design synthetic morphogen systems that have programming functionality but at the same time do not interfere with biological (non-synthetic) morphogen systems.

Green fluorescent protein

Green fluorescent protein (GFP) is a molecule displaying green fluorescence upon exposure to blue-to-ultraviolet light. GFP is often used in biomedical protein expression experiments. For instance, it has been shown that the GFP gene can be expressed in specific cells, particular organs, or whole organisms. Now, Toda and colleagues have shown that (soluble) GFP can be used as a synthetic morphogen.

Reference

Satoshi Toda, Wesley L. McKeithan, Teemu J. Hakkinen, Pilar Lopez, Ophir D. Klein, and Wendell A. Lim. Engineering synthetic morphogen systems that can program multicellular patterning, Science 370, 327-331 (2020).

DOI: 10.1126/science.abc0033

URL: https://science.sciencemag.org/content/370/6514/327

Further information

About WPI nanoLSI Kanazawa University Hiroe Yoneda Vice Director of Public Affairs WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University Kakuma-machi, Kanazawa 920-1192, Japan Email: [emailprotected]Tel: +81 (76) 234-4550

About Nano Life Science Institute (WPI-NanoLSI)

https://nanolsi.kanazawa-u.ac.jp/en/

Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology. The objective of this initiative is to form world-tier research centers. NanoLSI combines the foremost knowledge of bio-scanning probe microscopy to establish 'nano-endoscopic techniques' to directly image, analyze, and manipulate biomolecules for insights into mechanisms governing life phenomena such as diseases.

About Kanazawa University

http://www.kanazawa-u.ac.jp/e/

As the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949. The University has three colleges and 17 schools offering courses in subjects that include medicine, computer engineering, and humanities.

The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture. The city of Kanazawa has a highly respected intellectual profile since the time of the fiefdom (1598-1867). Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

SOURCE Kanazawa University

See more here:
Kanazawa University research: Engineering biological pattern formation with synthetic morphogens - PRNewswire

This article was originally published here

J Hematol Oncol. 2020 Nov 2;13(1):145. doi: 10.1186/s13045-020-00965-4.

ABSTRACT

BACKGROUND: Drug-loaded nanoparticles have established their benefits in the fight against multiple myeloma; however, ligand-targeted nanomedicine has yet to successfully translate to the clinic due to insufficient efficacies reported in preclinical studies.

METHODS: In this study, liposomal nanoparticles targeting multiple myeloma via CD38 or CD138 receptors are prepared from pre-synthesized, purified constituents to ensure increased consistency over standard synthetic methods. These nanoparticles are then tested both in vitro for uptake to cancer cells and in vivo for accumulation at the tumor site and uptake to tumor cells. Finally, drug-loaded nanoparticles are tested for long-term efficacy in a month-long in vivo study by tracking tumor size and mouse health.

RESULTS: The targeted nanoparticles are first optimized in vitro and show increased uptake and cytotoxicity over nontargeted nanoparticles, with CD138-targeting showing superior enhancement over CD38-targeted nanoparticles. However, biodistribution and tumor suppression studies established CD38-targeted nanoparticles to have significantly increased in vivo tumor accumulation, tumor cell uptake, and tumor suppression over both nontargeted and CD138-targeted nanoparticles due to the latters poor selectivity.

CONCLUSION: These results both highlight a promising cancer treatment option in CD38-targeted nanoparticles and emphasize that targeting success in vitro does not necessarily translate to success in vivo.

PMID:33138841 | DOI:10.1186/s13045-020-00965-4

See more here:
In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma - DocWire News

Global Nanorobotics Market report provides in-depth analysis and detailed information by key players, end-users, applications, Competitor analysis, geography, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends, CAGR value and how it is expected to reach from 2020 to 2026.

Global Nanorobotics Market Report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nanorobotics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

The global Nanorobotics market was valued at US$ 5.11 Bn in 2018 and is expected to reach US$ 10.71 Bn in 2026, growing at a CAGR of 9.9% during the forecast period.

Request for Sample Copy of Nanorobotics market Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.alltheresearch.com/sample-request/299

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.

Key Players covered in this Nanorobotics market report are

The report splits by major applications:

Then report analyzed by types:

Any questions, Lets discuss with the analyst @ https://www.alltheresearch.com/speak-to-analyst/299

The Study Objectives Are:

The Nanorobotics industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions offered.

With the tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The Nanorobotics Market report provides key statistics on the market status of the Nanorobotics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Get Brief Information on Pre COVID-19 Analysis and Post COVID-19 Opportunities in Nanorobotics Market at https://www.alltheresearch.com/impactC19-request/299

How Report will help you to make decisions for business:

About AllTheResearch:

AllTheResearch was formed with the aim of making market research a significant tool for managing breakthroughs in the industry. As a leading market research provider, the firm empowers its global clients with business-critical research solutions. The outcome of our study of numerous companies that rely on market research and consulting data for their decision-making made us realise, that its not just sheer data-points, but the right analysis that creates a difference. While some clients were unhappy with the inconsistencies and inaccuracies of data, others expressed concerns over the experience in dealing with the research-firm. Also, same-data-for-all-business roles was making research redundant. We identified these gaps and built AllTheResearch to raise the standards of research support.

For All Your Research Needs, Reach Out us at:

Contact Name: Rohan S.

Email: [emailprotected]

Phone: +1 (407) 768-2028

See the article here:
Nanorobotics Market Growth, Recent Trends By Regions, Type, Application And Geographical Analysis To 2026 - The Think Curiouser